Simvastatin and clarithromycin — GPhC CRA MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: C — Clarithromycin can increase simvastatin exposure and myopathy risk
Clarithromycin is a strong inhibitor of CYP3A4 and can markedly increase simvastatin concentrations. This increases the risk of myopathy and rhabdomyolysis. The pharmacist should query management, such as temporarily withholding simvastatin or selecting an alternative antibiotic where appropriate. The interaction is not a simple absorption issue.
Reference: BNF